Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

NCT00399711 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

560

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: repaglinide and metformin combination tablet
DRUG: rosiglitazone and metformin combination tablet

Sponsor

Novo Nordisk A/S